-
Published 1/2/2026
Barata PC, Corrigan JK, La J, Culnan JM, Akama-Garren E, Dulberger KN, Dumontier C, Hansen J, Bihn JR, Bitting RL, Brophy MT, Cheng HH, Cooperberg MR, Do NV, Dorff T, Fojo AT, Gaziano JM, Goryachev SD, Halabi S, Hauger RL, Nanus DM, Rebbeck TR, Pan CX, Schoen MW, Swinnerton KN, Myrie K, Ramoni RB, Fillmore NR, Paller CJ, Rettig MB. Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer. JAMA Netw Open. 2026 Jan 02; 9(1):e2551231. PMID: 41543856.
-
Published 1/1/2026
Cooperberg MR, Bihn JR, Culnan JM, La J, Goryachev SD, Chen DCR, Soloviev O, Lee G, Corrigan JK, Swinnerton KN, Nickols NG, Dulberger KN, Barata P, Bitting RL, Brophy MT, Cheng HH, De Hoedt A, Do NV, Freedland SJ, Garraway IP, Gaziano JM, Halabi S, Hauger RL, Loeb S, Nanus DM, Rebbeck TR, Rettig MB, Pan CX, Myrie K, Ramoni RB, Fillmore NR, Paller CJ. Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance. JAMA Oncol. 2026 Jan 01; 12(1):111-113. PMID: 41264314.
-
Published 11/20/2025
Tosi HM, Zheng C, Tarren AH, Yellanki M, Miller SJ, Soloviev OV, Corrigan JK, Schneeloch GR, Katki HA, Kearney LE, Caverly TJ, Tanner NT, Wiener RS, Brophy M, Fillmore NR, Do NV, Elbers DC. Rapid Support and Implementation of an Application for the Prediction Augmented Screening Initiative (PASI) Planning Phase Through the Enabling Technologies for Rapid Learning Health Systems Platform (ENTHRALL) at the Department of Veterans Affairs (VA). Cancer Inform. 2025; 24:11769351251389781. PMID: 41281611.
-
Published 11/20/2025
Ferri GM, Yildirim C, Do NV, Brophy MT, Munshi NC, Edwards CV, Fillmore NR. Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple Myeloma. EJHaem. 2025 Dec; 6(6):e70153. PMID: 41278511.
-
Published 11/17/2025
Barry A, England BR, Sayles H, Helget LN, Androsenko M, Wu H, Michaud K, Kramer B, Newcomb JA, Brophy MT, Davis-Karim A, Ferguson R, Pillinger MH, Neogi T, Palevsky PM, O'Dell JR, Mikuls TR. Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial. Arthritis Care Res (Hoboken). 2026 Feb; 78(2):259-269. PMID: 40771143.